Vanguard Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-90,003
| Closed | -$38K | – | 4189 |
|
|
2018
Q4 | $38K | Sell |
90,003
-284,214
| -76% | -$177K | ﹤0.01% | 4093 |
|
|
2018
Q3 | $361K | Hold |
374,217
| – | – | ﹤0.01% | 3904 |
|
|
2018
Q2 | $909K | Buy |
374,217
+768
| +0.2% | +$1.88K | ﹤0.01% | 3714 |
|
|
2018
Q1 | $892K | Buy |
373,449
+45,959
| +14% | +$116K | ﹤0.01% | 3670 |
|
|
2017
Q4 | $786K | Buy |
327,490
+100
| +0% | +$277 | ﹤0.01% | 3663 |
|
|
2017
Q3 | $1.03M | Sell |
327,390
-75,033
| -19% | -$241K | ﹤0.01% | 3584 |
|
|
2017
Q2 | $1.62M | Buy |
402,423
+56,182
| +16% | +$245K | ﹤0.01% | 3448 |
|
|
2017
Q1 | $1.28M | Buy |
346,241
+90,682
| +35% | +$285K | ﹤0.01% | 3520 |
|
|
2016
Q4 | $496K | Buy |
255,559
+161,443
| +172% | +$584K | ﹤0.01% | 3735 |
|
|
2016
Q3 | $585K | Sell |
94,116
-89,933
| -49% | -$554K | ﹤0.01% | 3722 |
|
|
2016
Q2 | $824K | Buy |
184,049
+4,387
| +2% | +$28.6K | ﹤0.01% | 3661 |
|
|
2016
Q1 | $1.89M | Buy |
179,662
+651
| +0.4% | +$12.9K | ﹤0.01% | 3405 |
|
|
2015
Q4 | $5.28M | Buy |
179,011
+5,026
| +3% | +$152K | ﹤0.01% | 2965 |
|
|
2015
Q3 | $5.5M | Buy |
173,985
+82,812
| +91% | +$3.96M | ﹤0.01% | 2924 |
|
|
2015
Q2 | $5.4M | Buy |
91,173
+5,497
| +6% | +$388K | ﹤0.01% | 2984 |
|
|
2015
Q1 | $9.16M | Buy |
85,676
+16,361
| +24% | +$1.56M | ﹤0.01% | 2685 |
|
|
2014
Q4 | $6.51M | Buy |
69,315
+6,645
| +11% | +$634K | ﹤0.01% | 2754 |
|
|
2014
Q3 | $4.81M | Buy |
62,670
+11,042
| +21% | +$870K | ﹤0.01% | 2844 |
|
|
2014
Q2 | $4.64M | Buy |
51,628
+5,353
| +12% | +$328K | ﹤0.01% | 2873 |
|
|
2014
Q1 | $2.48M | Buy |
46,275
+6,800
| +17% | +$224K | ﹤0.01% | 3127 |
|
|
2013
Q4 | $994K | Buy |
39,475
+77
| +0.2% | +$1.83K | ﹤0.01% | 3418 |
|
|
2013
Q3 | $1.08M | Buy |
39,398
+10,621
| +37% | +$342K | ﹤0.01% | 3346 |
|
|
2013
Q2 | $1.04M | Buy |
+28,777
| New | +$1.08M | ﹤0.01% | 3302 |
|
Vanguard Group's PTX Position: Q1 2019 in Review
Vanguard Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 90,003 shares — an estimated $38K sold.
Vanguard Group first reported a position in PTX in Q2 2013 and held it in 23 quarters. The position peaked at $9.16M in Q1 2015. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Vanguard Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Vanguard Group sold 90,003 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $38K.
- Vanguard Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 23 quarters.
- Vanguard Group's Pernix Therapeutics Holdings, Inc. position peaked at $9.16M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Vanguard Group's 13F filing for Q1 2019, filed 15 May 2019.